These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 5595730)
1. [Proliferative diabetic retinopathy with negative kidney findings]. Fischer F Dtsch Z Verdau Stoffwechselkr; 1967 Nov; 27(3):123-7. PubMed ID: 5595730 [No Abstract] [Full Text] [Related]
2. Diabetic retinopathy before and after renal transplantation: a longitudinal study. Mittal NS; Bajwa GS; Sandhu JS Transplant Proc; 2005 Jun; 37(5):2077-9. PubMed ID: 15964343 [TBL] [Abstract][Full Text] [Related]
3. [Kidney function in patients with diabetic microangiopathies]. Lüdtke E Z Gesamte Inn Med; 1966 Mar; 21(5):134-7. PubMed ID: 5985920 [No Abstract] [Full Text] [Related]
4. [Eye fundus of the diabetic patient with nephropathy and hypertensive retinopathy. Macroangiopathic complications]. Leys AM Bull Soc Belge Ophtalmol; 1995; 256():49-59. PubMed ID: 8581231 [TBL] [Abstract][Full Text] [Related]
5. [Kidney changes in patients with proliferative diabetic retinopathy]. Stein G; Kresse S; Dietze U; Deufrains A Z Gesamte Inn Med; 1984 Jul; 39(13):309-11. PubMed ID: 6485427 [TBL] [Abstract][Full Text] [Related]
7. [Remission of non-proliferative diabetic retinopathy following central retinal artery obstruction]. Brahim R; Khairallah M; Zbiba H; Ladjimi A; Chechia N J Fr Ophtalmol; 1996; 19(10):610-4. PubMed ID: 8959102 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-dependent anaemia: a possible complication of diabetic neuropathy. Hadjadj S; Torremocha F; Fanelli A; Brizard A; Bauwens M; Maréchaud R Diabetes Metab; 2001 Jun; 27(3):383-5. PubMed ID: 11431605 [TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality in patients with diabetic retinopathy. Sharma NK; Archer DB; Hadden DR; Merrett JD; Maguire CJ Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):83-9. PubMed ID: 6943838 [TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and biochemical aspects of diabetic retinopathy and nephropathy]. Riabchuk OG; Kliachko VR; Tirkina TN Klin Med (Mosk); 1970 Jul; 48(7):34-7. PubMed ID: 5494091 [No Abstract] [Full Text] [Related]
12. Florid diabetic retinopathy and its systemic implications. Lanzetta P; Bandello F; Menchini U; Brancato R Diabetes Nutr Metab; 1999 Dec; 12(6):418-9. PubMed ID: 10782564 [No Abstract] [Full Text] [Related]
13. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of nephro- and retinopathies in patients with diabetes mellitus of various degrees of severity]. Strubovshchikov EP; Savina PN Ter Arkh; 1984; 56(10):92-4. PubMed ID: 6523368 [No Abstract] [Full Text] [Related]
15. [Clinical and epidemiological aspects of diabetic retinopathy and its relationship with diabetic nephropathy]. Evgrafov VIu; Mamaeva GG; Bishele NA; Liudina LI Vestn Oftalmol; 1996; 112(1):40-3. PubMed ID: 8659071 [TBL] [Abstract][Full Text] [Related]
16. [Proliferating diabetic retinopathy: at the ages from 20-30 years (author's transl)]. Fischer F Klin Monbl Augenheilkd; 1974 Nov; 165(5):767-70. PubMed ID: 4468996 [No Abstract] [Full Text] [Related]
17. Probabilistic approach to developing nephropathy in diabetic patients with retinopathy. Ballone E; Colagrande V; Di Nicola M; Di Mascio R; Di Mascio C; Capani F Stat Med; 2003 Dec; 22(24):3889-97. PubMed ID: 14673945 [TBL] [Abstract][Full Text] [Related]